James Edgemond Insider Trading Activity
James Edgemond has been net-selling over the last 12 months with 0 purchases and 293 sales across 1 company.
UTHR is the most-traded position with 293 trades. The largest single transaction was a sale of UTHR for $3.6M on Dec 1, 2025.
Performance Scorecard
Forward stock performance after each transaction by James Edgemond. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -0.7% | 51% | 302 |
| 90 days | — | -0.4% | 51% | 204 |
| 120 days | — | -15.5% | 1% | 98 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersUTHR · UNITED THERAPEUTICS Corp
🔒 Subscribe to see trade entries
Pro members see exactly when James Edgemond bought and sold UTHR.
Upgrade to ProRecent Trades
Showing the 50 most recent of 302 disclosed trades.
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jun 22, 2026 | UTHR | Sell | 2,266 | $538.23 | $1.2M | −9.2% | CFO | |
Jun 22, 2026 | UTHR | Sell | 280 | $539.83 | $151K | −1.4% | CFO | |
Jun 22, 2026 | UTHR | Sell | 865 | $534.98 | $463K | −3.1% | CFO | |
Jun 22, 2026 | UTHR | Sell | 1,250 | $541.25 | $677K | −6.2% | CFO | |
Jun 22, 2026 | UTHR | Sell | 1,994 | $539.13 | $1.1M | −8.9% | CFO | |
Jun 22, 2026 | UTHR | Sell | 164 | $534.06 | $88K | −0.6% | CFO | |
Jun 22, 2026 | UTHR | Sell | 840 | $537.18 | $451K | −3.3% | CFO | |
Jun 22, 2026 | UTHR | Sell | 1,091 | $536.05 | $585K | −4.1% | CFO | |
Jun 4, 2026 | UTHR | Sell | 440 | $542.78 | $239K | −1.6% | CFO | |
Jun 4, 2026 | UTHR | Sell | 2,749 | $548.04 | $1.5M | −11.9% | CFO | |
Jun 4, 2026 | UTHR | Sell | 1,545 | $544.94 | $842K | −5.8% | CFO | |
Jun 4, 2026 | UTHR | Sell | 1,033 | $547.00 | $565K | −4.3% | CFO | |
Jun 4, 2026 | UTHR | Sell | 120 | $539.64 | $65K | −0.4% | CFO | |
Jun 4, 2026 | UTHR | Sell | 1,129 | $545.89 | $616K | −4.5% | CFO | |
Jun 4, 2026 | UTHR | Sell | 480 | $541.14 | $260K | −1.7% | CFO | |
Jun 4, 2026 | UTHR | Sell | 1,086 | $544.11 | $591K | −3.9% | CFO | |
Jun 4, 2026 | UTHR | Sell | 1,298 | $549.06 | $713K | −6.4% | CFO | |
May 21, 2026 | UTHR | Sell | 2,197 | $566.12 | $1.2M | −10.4% | CFO | |
May 21, 2026 | UTHR | Sell | 920 | $562.01 | $517K | −3.2% | CFO | |
May 21, 2026 | UTHR | Sell | 1,765 | $565.10 | $997K | −7.7% | CFO | |
May 21, 2026 | UTHR | Sell | 2,081 | $564.10 | $1.2M | −8.4% | CFO | |
May 21, 2026 | UTHR | Sell | 320 | $560.03 | $179K | −1.1% | CFO | |
May 21, 2026 | UTHR | Sell | 40 | $557.85 | $22K | −0.1% | CFO | |
May 21, 2026 | UTHR | Sell | 2,677 | $563.12 | $1.5M | −9.7% | CFO | |
May 18, 2026 | UTHR | Sell | 40 | $570.18 | $23K | −0.2% | CFO | |
May 18, 2026 | UTHR | Sell | 1,322 | $569.56 | $753K | −6.5% | CFO | |
May 18, 2026 | UTHR | Sell | 1,304 | $568.43 | $741K | −6.1% | CFO | |
May 18, 2026 | UTHR | Sell | 2,785 | $568.48 | $1.6M | −11.4% | CFO | |
May 18, 2026 | UTHR | Sell | 1,796 | $566.39 | $1.0M | −6.9% | CFO | |
May 18, 2026 | UTHR | Sell | 2,131 | $565.44 | $1.2M | −7.5% | CFO | |
May 18, 2026 | UTHR | Sell | 200 | $562.91 | $113K | −0.7% | CFO | |
May 18, 2026 | UTHR | Sell | 422 | $564.30 | $238K | −1.5% | CFO | |
May 14, 2026 | UTHR | Sell | 80 | $568.74 | $45K | −0.3% | CFO | |
May 14, 2026 | UTHR | Sell | 307 | $577.93 | $177K | −1.6% | CFO | |
May 14, 2026 | UTHR | Sell | 293 | $576.75 | $169K | −1.5% | CFO | |
May 14, 2026 | UTHR | Sell | 1,712 | $575.78 | $986K | −8.0% | CFO | |
May 14, 2026 | UTHR | Sell | 3,419 | $574.76 | $2.0M | −13.8% | CFO | |
May 14, 2026 | UTHR | Sell | 2,456 | $574.04 | $1.4M | −9.0% | CFO | |
May 14, 2026 | UTHR | Sell | 603 | $571.53 | $345K | −2.1% | CFO | |
May 14, 2026 | UTHR | Sell | 970 | $572.78 | $556K | −3.5% | CFO | |
May 11, 2026 | UTHR | Sell | 89 | $576.68 | $51K | −0.4% | CFO | |
May 11, 2026 | UTHR | Sell | 530 | $575.26 | $305K | −2.5% | CFO | |
May 11, 2026 | UTHR | Sell | 661 | $574.57 | $380K | −3.0% | CFO | |
May 11, 2026 | UTHR | Sell | 480 | $573.22 | $275K | −2.1% | CFO | |
May 11, 2026 | UTHR | Sell | 1,356 | $572.32 | $776K | −5.6% | CFO | |
May 11, 2026 | UTHR | Sell | 2,059 | $570.17 | $1.2M | −7.5% | CFO | |
May 11, 2026 | UTHR | Sell | 1,496 | $571.42 | $855K | −5.9% | CFO | |
May 11, 2026 | UTHR | Sell | 893 | $577.59 | $516K | −4.3% | CFO | |
May 11, 2026 | UTHR | Sell | 1,289 | $569.46 | $734K | −4.5% | CFO | |
May 11, 2026 | UTHR | Sell | 476 | $578.42 | $275K | −2.4% | CFO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | 302 | $179.2M |
Other insiders at UNITED THERAPEUTICS Corp
9 other tracked filers at UTHR.